Rating
Buy
Price target
$205
Previous
$197
Implied upside
+39%

HSBC analyst Stephen Bersey upgraded Palantir (NASDAQ: PLTR) from Hold to Buy with a price target of $205.00 (from $197.00).

“Revenue at USD1,407m was up 70% y-o-y and above HSBCe (USD1,342m) and consensus (USD 1,340m). Non-GAAP operating profit of USD798m grew 114% y-o-y to beat HSBCe and consensus by 13 14%.

Non-GAAP operating margin was 56.8%, +11.7ppt y-o-y and above HSBCe (52.8%) and consensus (52.2%). Non-GAAP EPS of USD0.25 was up 84.9% y-o-y and USD0.02 above HSBCe and consensus.

For 2026, non-GAAP operating profit guidance is USD4,134m (pre-results consensus: USD3,127m, pre-results HSBCe: USD4,222m).

We now expect 2026e revenue of USD7,527m, +68.2% y-o-y (2025: +56.2%) and non-GAAP operating profit of USD4,483m (2025: USD2,254m).

Though PLTR trades at a significant premium, we see continued strength for many quarters and think the stock merits support. We upgrade our rating to Buy (from Hold).

We expect a 58.8% US commercial segment revenue CAGR of 58.8% in 2025-29e to USD9.3bn in 2029 after surging 137% y-o-y to USD507m in 4Q25 (3Q25: +122%).

More importantly, total contract value (TVC) of new agreements was USD1,344m in 4Q25 (3Q25: USD1,310m), suggesting potential upside to its revenue run-rate, though we have seen anecdotes and reports suggesting that the ROIC on internal AI projects that enterprises are experimenting with (not specific to Palantir) is often disappointing.

This may slow the tempo of future contract signings, in our opinion.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.